G6PC2 and type 1 diabetes mellitus: Importantly, the DR15-restricted GAD- and IGRP-specific Tregs were able to suppress the proliferation of GAD- and IGRP-specific effector T cells, including those activated by the T1D-risk DQ8 molecule.